SheldonDx Terms of Service

These Terms of Service (“Terms”) form a binding agreement between you (“Clinician”, “you”) and ZEBRA HEALTH LTD (“SheldonDx”, “we”, “us”) governing access to and use of the SheldonDx platform at sheldondx.com and associated APIs (“Platform”).

By creating an account or using the Platform, you confirm that you have read, understood, and agree to these Terms. If you do not agree, do not use the Platform.

To use SheldonDx you must:

• Be a qualified healthcare professional licensed to practice in your jurisdiction
• Hold current registration with a relevant professional body (e.g., HCPC, GMC, BPS in the UK; RCI, MCI in India; AHPRA in Australia)
• Be using the Platform for legitimate clinical, educational, or research purposes
• Be at least 18 years of age

SheldonDx reserves the right to verify credentials at any time and to suspend or terminate accounts where eligibility cannot be confirmed. Provisional accounts (unverified) may have access to demo assessments only.

The ADOS-2 and ADI-R are proprietary clinical instruments published by Western Psychological Services (WPS). SheldonDx provides software tooling to assist clinicians who are already trained and licensed to administer these instruments.

At first use of a live session instrument you will be asked to complete an attestation confirming your WPS licence. This attestation is recorded with a timestamp in your account.

Before initiating any session recording (Recall.ai bot) or live AI transcription, you must:

• Obtain explicit verbal and written informed consent from the patient, or (for children) their parent/legal guardian
• Explain that the session will be recorded, AI-transcribed, and that notes will be retained in the clinical record
• Explain the retention period (7 years for adults, 25 years for children)
• Retain a copy of the signed consent form in your own clinical records

You acknowledge and accept the following known limitations of SheldonDx AI:

• Hallucinations: Large language models can generate plausible-sounding but factually incorrect clinical statements
• Training data bias: AI models may reflect biases in historical diagnostic literature, including under-recognition of autism in women, LGBTQ+ individuals, and non-white populations
• Not validated as a diagnostic instrument: Clinical reasoning-support outputs have not been subject to prospective clinical validation studies
• Context limits: Automated reasoning support operates on a limited window of evidence and may miss clinically significant information present in the full assessment history
• No human observation: Automated reasoning support cannot observe or interpret non-verbal cues, affect, prosody, or subtle behavioral signals the way a trained clinician can

SheldonDx warrants that the AI outputs are generated by the described system. We make no warranty as to their clinical accuracy, validity, or fitness for any particular diagnostic purpose.

You must not use SheldonDx to:

• Produce, distribute, or submit diagnoses or clinical reports without your own independent review
• Use AI outputs to train third-party machine learning models
• Share access credentials with any other person
• Attempt to extract, reverse-engineer, or reproduce clinical instrument content protected by WPS copyright
• Process data relating to patients who have not been referred to you in your capacity as a qualified clinician
• Use the Platform for any purpose that violates applicable law or your professional code of conduct
• Attempt to circumvent security controls or access data belonging to other clinicians

Plans

Free trial: 3 diagnostic assessments. No card required during trial.

Billing

• Payments processed by Razorpay in INR. Card data never touches SheldonDx servers.
• Monthly subscriptions renew automatically unless cancelled before the renewal date.
• Refunds: available within 7 days of a charge if no assessments have been completed in that billing period. Contact info@sheldondx.com.
• No refunds for completed assessments.

You agree to:

• Treat all patient data processed via SheldonDx as strictly confidential
• Not export or share patient records outside of your clinical workflow without appropriate consent
• Comply with your jurisdiction’s data protection obligations (UK GDPR, India DPDP Act, or other applicable law) independently of SheldonDx’s own obligations
• Notify SheldonDx promptly if you become aware of any unauthorised access to data via your account

See our Privacy Policy for full details of how data is stored, processed, and retained.

• India DPDP Act 2023: Primary compliance obligation. See Privacy Policy §9.
• GDPR / UK GDPR: Measures in progress; ISO 27701 target Q3 2026. See Privacy Policy §10.
• HIPAA: No BAA with all sub-processors yet. Do not use with US patients. Target Q4 2026. See Privacy Policy §11.

Termination by you

You may close your account at any time from Settings. On closure, your personal account data will be deleted within 30 days. Clinical records (patient assessment data) are retained for the statutory period (7/25 years) as described in the Privacy Policy, even after account closure.

Termination by SheldonDx

We may suspend or terminate your account immediately if you breach these Terms, misrepresent credentials, or if continued access poses a risk to patient safety or data security. We will provide 7 days’ notice for non-breach terminations.

Data export

Before termination you may request a data export in JSON and PDF formats from Settings → Export. Exports are available for 30 days after account closure.

These Terms are governed by the laws of India. Disputes shall be resolved by binding arbitration under the Arbitration and Conciliation Act, 1996 (India), seated in Bangalore, Karnataka.

For clinicians registered in the United Kingdom: disputes may also be brought before the courts of England and Wales, which shall have concurrent jurisdiction with the Indian arbitration clause for UK-resident clinicians only.

Before initiating formal proceedings, both parties agree to attempt good-faith resolution by contacting info@sheldondx.com.

We will notify you of material changes by email at least 30 days before the new terms take effect. Continued use after the effective date constitutes acceptance. Non-material changes (typos, clarifications, formatting) take effect immediately with an updated effective date.